Single-center, Randomized, Double-blind, 2-treatment, 2-period Crossover Trial in Healthy Subjects to Demonstrate PK Bioequivalence and to Compare the PD Properties of Julphar Insulin 30/70 and Huminsulin Profil III
Phase of Trial: Phase I
Latest Information Update: 13 Jun 2017
At a glance
- Drugs Insulin (Primary)
- Indications Diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Gulf Pharmaceutical Industries
- 13 Jun 2017 Results (n=51) presented at the 77th Annual Scientific Sessions of the American Diabetes Association.
- 01 Aug 2016 Status changed from recruiting to completed.
- 24 Feb 2016 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History